Literature DB >> 17617760

Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons.

Neil J Wimmer1, Kinji Sathi, Tiffany L Chen, Raymond R Townsend, Debbie L Cohen.   

Abstract

White coat hypertension (WCH) is considered by some but not all investigators to be a benign condition without increased cardiovascular risk. Pulse wave analysis is a noninvasive method to measure how the reflected pressure wave interacts with central aortic blood pressure (BP) and to assess how it is related to vascular stiffness. The purpose of the study was to compare central aortic BP in normotensive and WCH participants. WCH participants were identified after ambulatory BP monitoring. Normotensive participants served as controls. Using radial artery applanation tonometry, aortic pulse wave analysis was performed. Augmentation index (AI), AI75, and differences in systolic BP between central aortic and peripheral vasculatures were calculated. Results show a difference in AI, AI75, (AI standardized to a heart rate of 75 beats per minute), and central aortic systolic pressures between WCH and normotensive participants. The WCH group had significantly higher systolic BP and pulse pressure; however, these were still within the normal range. In summary, WCH participants had increased central aortic pressures compared with normotensives, supporting the potential for increased cardiovascular risk in WCH.

Entities:  

Mesh:

Year:  2007        PMID: 17617760      PMCID: PMC8109852          DOI: 10.1111/j.1524-6175.2007.06553.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  19 in total

1.  Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT).

Authors:  Carmel M McEniery; Ian R Hall; Ahmad Qasem; Ian B Wilkinson; John R Cockcroft
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

Review 2.  Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.

Authors:  Wilmer W Nichols
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

Review 3.  An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry.

Authors:  Michael F O'Rourke; Audrey Adji
Journal:  Curr Opin Cardiol       Date:  2005-07       Impact factor: 2.161

4.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

5.  Circulating homocysteine levels in sustained and white coat hypertension.

Authors:  S D Pierdomenico; A Bucci; D Lapenna; F M Lattanzio; L Talone; F Cuccurullo; A Mezzetti
Journal:  J Hum Hypertens       Date:  2003-03       Impact factor: 3.012

6.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

Review 8.  Task Force II: blood pressure measurement and cardiovascular outcome.

Authors:  J A Staessen; R Asmar; M De Buyzere; Y Imai; G Parati; K Shimada; G Stergiou; J Redón; P Verdecchia
Journal:  Blood Press Monit       Date:  2001-12       Impact factor: 1.444

9.  White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.

Authors:  P H Gustavsen; A Høegholm; L E Bang; K S Kristensen
Journal:  J Hum Hypertens       Date:  2003-12       Impact factor: 3.012

10.  Cardiovascular risk in white-coat and sustained hypertensive patients.

Authors:  Hilde Celis; Jan A Staessen; Lutgarde Thijs; Frank Buntinx; Marc De Buyzere; Elly Den Hond; Robert H Fagard; Eoin T O'Brien
Journal:  Blood Press       Date:  2002       Impact factor: 2.835

View more
  3 in total

1.  Associations between plasma homocysteine levels, aortic stiffness and wave reflection in patients with arterial hypertension, isolated office hypertension and normotensive controls.

Authors:  G Vyssoulis; E Karpanou; S-M Kyvelou; D Adamopoulos; T Gialernios; E Gymnopoulou; D Cokkinos; C Stefanadis
Journal:  J Hum Hypertens       Date:  2009-06-11       Impact factor: 3.012

2.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

3.  Arterial Stiffness in Treated Hypertensive Patients With White-Coat Hypertension.

Authors:  Jessica Barochiner; Lucas S Aparicio; José Alfie; Margarita S Morales; Paula E Cuffaro; Marcelo A Rada; Marcos J Marin; Carlos R Galarza; Gabriel D Waisman
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-28       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.